EPISODE · Mar 3, 2026 · 1 MIN
Ocular Toxicity From New Oncology Agents: Safety Review
from TheBrief.Health · host TheBrief.Health
Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.
What this episode covers
Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.
NOW PLAYING
Ocular Toxicity From New Oncology Agents: Safety Review
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m